Target intelligence / Profile preview

Haemophilus influenzae outer membrane protein

Molecular classification
Other (bacterial outer membrane protein), Adhesin, Trimeric autotransporter, Porin, Lipoprotein
01

Overview

Haemophilus influenzae outer membrane proteins" does not refer to a single molecule but a collective set of surface-expressed proteins that play critical roles in adherence to host cells, immune evasion, nutrient acquisition, and pathogenesis of infection[2][1][8][6][11]. Notable proteins include P2, the major porin, P5, a porin and complement resistance factor, Protein E (PE) which binds host molecules and acquires hemin, Hap and Hia/Hsf, which act as adhesins and autotransporters critical for colonization and microcolony formation[1][10][11]. Many of these proteins are being investigated as potential vaccine antigens and therapeutic targets due to their surface exposure and role in virulence, but their antigenic variability and redundant functions present challenges for broad-spectrum vaccine development[6][11]. Some have subtype-specific features relevant in epidemiology and pathogenesis studies[4][6].

Other names
Outer membrane protein P2 (OmpP2)Outer membrane protein P5 (OmpP5)Protein E (PE)Haemophilus adhesion and penetration protein (Hap)Haemophilus influenzae adhesin (Hia)Haemophilus surface fibril (Hsf)Protein DProtein kProtein aProtein bProtein cOuter membrane protein A-like (OmpA-like)
02

Mechanism of action

Vaccine-induced antibody-mediated neutralization or complement activation[6][11] Proposed role as vaccine antigens, leading to immune clearance of bacteria[6][11]

03

Biological functions

Adherence to epithelial cellsImmune evasion (complement resistance, binding of host factor H)Nutrient acquisition (e.g., hemin acquisition)Bacterial aggregation and microcolony formationSerum resistance
04

Disease associations

Infection (especially respiratory tract infections)Carrier state and transmissionPotential involvement in invasive Haemophilus influenzae disease
05

Safety considerations

Antigenic variation of surface proteins can reduce vaccine efficacy and complicate broad protection[6][11]Potential for non-target effects in development of broadly protective vaccines due to heterogeneity of protein sequences[6][11]
06

Interacting drugs

None conclusively established; outer membrane proteins are targets for experimental vaccines and under exploration for antibody-based therapies[11]
07

Biomarkers

Outer membrane protein profiles (e.g., P2 and P5 subtype analysis) for strain differentiation and epidemiology[6][4]Surface protein expression as possible diagnostic marker or candidate for vaccine coverage testing[6][4]

Beyond the preview

Go deeper on Haemophilus influenzae outer membrane protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haemophilus influenzae outer membrane protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call